Search

Your search keyword '"Hui, Vicki Wing‐Ki"' showing total 136 results
Start Over Author "Hui, Vicki Wing‐Ki"
136 results on '"Hui, Vicki Wing‐Ki"'

16. HBsAg seroclearance decreases risk of hepatocellular carcinoma but not hepatic decompensation in nucleos (t)ide analogue-treated cirrhotic patients with complete hepatitis B virus suppression: a territory-wide cohort study

Author

Yip, Terry Cheuk-Fung, primary, Hui, Vicki Wing-Ki, additional, Wong, Vincent Wai-Sun, additional, Yam, Tsz Fai, additional, Lai, Che To, additional, Liang, Yan, additional, Tse, Yee-Kit, additional, Chan, Henry LY, additional, and Wong, Grace Lai-Hung, additional

Published
2023
Full Text
View/download PDF

19. Duration of type 2 diabetes and liver-related events in nonalcoholic fatty liver disease: A landmark analysis

Author

Zhang, Xinrong, primary, Yip, Terry Cheuk-Fung, additional, Tse, Yee-Kit, additional, Hui, Vicki Wing-Ki, additional, Li, Guanlin, additional, Lin, Huapeng, additional, Liang, Lilian Yan, additional, Lai, Jimmy Che-To, additional, Chan, Henry Lik-Yuen, additional, Chan, Stephen Lam, additional, Kong, Alice Pik-Shan, additional, Wong, Grace Lai-Hung, additional, and Wong, Vincent Wai-Sun, additional

Published
2023
Full Text
View/download PDF

20. Incidence of hepatocellular carcinoma and mortality in chronic viral hepatitis in an Asian population with and without HIV infection.

Author

Lui, Grace Chung‐Yan, Hui, Vicki Wing‐Ki, Sze, Shun‐Fung, Wong, Bonnie Chun‐Kwan, Cheung, Catherine, Lee, Man‐Po, Yip, Terry Cheuk‐Fung, Tse, Yee‐Kit, Lai, Jimmy Che‐To, Chan, Henry Lik‐Yuen, Wong, Vincent Wai‐Sun, Hui, Yee‐Tak, and Wong, Grace Lai‐Hung

Subjects
*HIV infections, *VIRAL hepatitis, *CHRONIC active hepatitis, *HEPATOCELLULAR carcinoma, *ASIANS, *PROPORTIONAL hazards models, *HIV-positive persons
Abstract

Summary: Background: It is uncertain whether people with HIV infection have a higher incidence of hepatocellular carcinoma (HCC) than the general population. Aims: To compare the incidence of HCC between people infected with HBV and/or HCV with and without HIV Methods: We performed a retrospective population‐based cohort study, involving people with HBV and/or HCV infection from 2001 to 2018. The primary endpoint was incidence of HCC; secondary endpoint was all‐cause mortality. We performed Cox proportional hazard regression models to estimate the hazard ratios (HR) of HIV for the primary and secondary endpoints. Results: We identified 1374 people infected with HIV and 39,908 people without HIV with HBV and/or HCV infection. Among those with HIV, 654 (47.6%) had HBV, 649 (47.2%) HCV and 71 (5.2%) HBV‐HCV‐co‐infection; they were younger, and had a higher prevalence of HCV and a lower prevalence of cirrhosis. The incidence rate estimates of HCC were, respectively, 1.5 (95% CI: 0.8–2.5) and 7.6 (95% CI 7.3‐8.0) per 1000 person‐years for those with and without HIV infection. Using multivariate Cox proportional hazard regression models, among people with HBV, HIV was associated with lower risk of HCC (adjusted HR: 0.376, 95% CI: 0.201–0.704, p = 0.01) and death (adjusted HR: 0.692, 95% CI: 0.552–0.867, p = 0.007). Risks of HCC were similar for HCV and HBV‐HCV co‐infection for people with and without HIV. Conclusions: Among individuals with HBV infection, the Incidence of HCC was lower in those with HIV. For HCV infection, incidence of HCC was similar between those with and without HIV. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

21. Trends in risk factor control and treatment among patients with non‐alcoholic fatty liver disease and type 2 diabetes between 2000 and 2020: A territory‐wide study

Author

Zhang, Xinrong, primary, Yip, Terry Cheuk‐Fung, additional, Tse, Yee‐Kit, additional, Hui, Vicki Wing‐Ki, additional, Li, Guanlin, additional, Lin, Huapeng, additional, Liang, Lilian Yan, additional, Lai, Jimmy Che‐To, additional, Lai, Mandy Sze‐Man, additional, Cheung, Johnny T. K., additional, Chan, Henry Lik‐Yuen, additional, Chan, Stephen Lam, additional, Kong, Alice Pik‐Shan, additional, Wong, Grace Lai‐Hung, additional, and Wong, Vincent Wai‐Sun, additional

Published
2023
Full Text
View/download PDF

25. Age and the relative importance of liver‐related deaths in nonalcoholic fatty liver disease

Author

Lin, Huapeng, primary, Yip, Terry Cheuk‐Fung, additional, Zhang, Xinrong, additional, Li, Guanlin, additional, Tse, Yee‐Kit, additional, Hui, Vicki Wing‐Ki, additional, Liang, Lilian Yan, additional, Lai, Jimmy Che‐To, additional, Chan, Stephen Lam, additional, Chan, Henry Lik‐Yuen, additional, Wong, Grace Lai‐Hung, additional, and Wong, Vincent Wai‐Sun, additional

Published
2022
Full Text
View/download PDF

33. Trends in risk factor control and treatment among patients with non-alcoholic fatty liver disease and type 2 diabetes between 2000 and 2020: A territory-wide study.

Author

Xinrong Zhang, Yip, Terry Cheuk-Fung, Yee-Kit Tse, Hui, Vicki Wing-Ki, Guanlin Li, Huapeng Lin, Liang, Lilian Yan, Lai, Jimmy Che-To, Lai, Mandy Sze-Man, Cheung, Johnny T. K., Chan, Henry Lik-Yuen, Chan, Stephen Lam, Kong, Alice Pik-Shan, Wong, Grace Lai-Hung, and Wong, Vincent Wai-Sun

Subjects
NON-alcoholic fatty liver disease, TYPE 2 diabetes, BLOOD pressure, GLYCEMIC control, HYPOGLYCEMIC agents
Abstract

Background & Aims: We aimed to determine the trends in risk factor control and treatment among patients with non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes (T2D) in 2000-2020. Methods: We conducted a territory-wide cohort study of adult patients with NAFLD and T2D diagnosed between 1 January 2000 and 31 July 2021 in Hong Kong. T2D was defined by use of any anti-diabetic agents, laboratory tests and/or diagnosis codes. Results: This study included 16,084 patients with NAFLD and T2D (mean age, 54.8 ± 12.0 years; 7124 male [44.3%]). The percentage of patients achieving individualised haemoglobin A1c (HbA1c) targets increased from 44.5% (95% confidence interval [CI], 42.9-46.1) to 64.8% (95% CI, 64.1-65.5), and percentage of patients achieving individualised low-density lipoprotein-cholesterol (LDL-C) targets increased from 23.3% (95% CI, 21.9-24.7) to 54.3% (95% CI, 53.5-55.1) from 2000-2005 to 2016-2020, whereas percentage of patients achieving blood pressure control (<140/90 mm Hg) remained static at 53.1-57.2%. Combination therapy for diabetes increased, especially among those with poor glycaemic control, but there was no increase in combination therapy for hypertension. Fewer cirrhotic patients achieved blood pressure control and individualised LDL-C targets, but they were more likely to achieve individualised HbA1c targets than non-cirrhotics. Metformin and statins were underused in cirrhotic patients. Younger patients (18-44 years) were less likely to achieve individualised HbA1c targets than middle-aged (45-64 years) and older ones (=65 years). Conclusions: From 2000 to 2020, glycaemic and lipid control improved significantly, whereas blood pressure control remained static among patients with NAFLD and T2D. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

35. Risk of liver‐related events by age and diabetes duration in patients with diabetes and nonalcoholic fatty liver disease

Author

Zhang, Xinrong, primary, Wong, Grace Lai‐Hung, additional, Yip, Terry Cheuk‐Fung, additional, Cheung, Johnny T. K., additional, Tse, Yee‐Kit, additional, Hui, Vicki Wing‐Ki, additional, Lin, Huapeng, additional, Lai, Jimmy Che‐To, additional, Chan, Henry Lik‐Yuen, additional, Kong, Alice Pik‐Shan, additional, and Wong, Vincent Wai‐Sun, additional

Published
2022
Full Text
View/download PDF

40. Angiotensin‐converting enzyme inhibitors prevent liver‐related events in nonalcoholic fatty liver disease

Author

Zhang, Xinrong, primary, Wong, Grace Lai‐Hung, additional, Yip, Terry Cheuk‐Fung, additional, Tse, Yee‐Kit, additional, Liang, Lilian Yan, additional, Hui, Vicki Wing‐Ki, additional, Lin, Huapeng, additional, Li, Guan‐Lin, additional, Lai, Jimmy Che‐To, additional, Chan, Henry Lik‐Yuen, additional, and Wong, Vincent Wai‐Sun, additional

Published
2022
Full Text
View/download PDF

44. Association of metformin use on metabolic acidosis in diabetic patients with chronic hepatitis B‐related cirrhosis and renal impairment

Author

Yip, Terry Cheuk‐Fung, primary, Chan, Raymond Ngai Chiu, additional, Wong, Vincent Wai‐Sun, additional, Tse, Yee‐Kit, additional, Liang, Lilian Yan, additional, Hui, Vicki Wing‐Ki, additional, Zhang, Xinrong, additional, Li, Guan‐Lin, additional, Chan, Henry Lik‐Yuen, additional, and Wong, Grace Lai‐Hung, additional

Published
2021
Full Text
View/download PDF

48. Reply

Author

Wong, Grace Lai-Hung, Hui, Vicki Wing-Ki, and Yip, Terry Cheuk-Fung

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results